EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MIF-Modulated Spinal Proteins Associated with Persistent Bladder Pain: A Proteomics Study

Shaojing Ye iD, Nilesh M Agalave, Fei Ma, Dlovan F D Mahmood, Asma Al-Grety, Payam E Khoonsari, Lin Leng iD, Camilla I Svensson, Richard Bucala, Kim Kultima iD, Pedro L Vera

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25084484 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Shaojing Ye und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research & Development, Lexington VA Health Care System, Lexington, KY 40502, USA. Hauptthemen laut MEDLINE: Macrophage Migration-Inhibitory Factors, Proteomics, Receptors, CXCR4. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIDDK NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder pain is a prominent symptom in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). We studied spinal mechanisms of bladder pain in mice using a model where repeated activation of intravesical Protease Activated Receptor-4 (PAR4) results in persistent bladder hyperalgesia (BHA) with little or no bladder inflammation. Persistent BHA is mediated by spinal macrophage migration inhibitory factor (MIF), and is associated with changes in lumbosacral proteomics. We investigated the contribution of individual spinal MIF receptors to persistent bladder pain as well as the spinal proteomics changes associated with relief of persistent BHA by spinal MIF antagonism. Female mice with persistent BHA received either intrathecal (i.t.) MIF monoclonal antibodies (mAb) or mouse IgG1 (isotype control antibody). MIF antagonism temporarily reversed persistent BHA (peak effect: 2 h), while control IgG1 had no effect. Moreover, i.t. antagonism of the MIF receptors CD74 and C-X-C chemokine receptor type 4 (CXCR4) partially reversed persistent BHA. For proteomics experiments, four separate groups of mice received either repeated intravesical scrambled peptide and sham i.t. injection (control, no pain group) or repeated intravesical PAR4 and: sham i.t.; isotype IgG1 i.t. (15 μg); or MIF mAb (15 μg). L6-S1 spinal segments were excised 2 h post-injection and examined for proteomics changes using LC-MS/MS. Unbiased proteomics analysis identified and relatively quantified 6739 proteins. We selected proteins that showed significant changes compared to control (no pain group) after intravesical PAR4 (sham or IgG i.t. treatment) and showed no significant change after i.t. MIF antagonism. Six proteins decreased during persistent BHA (V-set transmembrane domain-containing protein 2-like confirmed by immunohistochemistry), while two proteins increased. Spinal MIF antagonism reversed protein changes. Therefore, spinal MIF and MIF receptors mediate persistent BHA and changes in specific spinal proteins. These novel MIF-modulated spinal proteins represent possible new targets to disrupt spinal mechanisms that mediate persistent bladder pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrophage Migration-Inhibitory FactorsProteomicsReceptors, CXCR4AnimalsFemaleMiceHyperalgesiaIntramolecular OxidoreductasesAntigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IICystitis, InterstitialSpinal CordUrinary BladderDisease Models, AnimalReceptors, Immunologic

Stichwörter der Autor:innen

CD74CXCR4macrophage migration inhibitory factorpersistent bladder painspinal proteins

Substanzen

Macrophage Migration-Inhibitory FactorsReceptors, CXCR4Intramolecular Oxidoreductasesinvariant chainAntigens, Differentiation, B-LymphocyteHistocompatibility Antigens Class IICXCR4 protein, mouseMif protein, mousemacrophage migration inhibitory factor receptorReceptors, Immunologic

Autor:innen und Institutionen

  • Research & Development, Lexington VA Health Care System, Lexington, KY 40502, USA.
  • Department of Medical Sciences, Clinical Chemistry, Uppsala University, SE-751 85 Uppsala, Sweden.
  • Department of Internal Medicine, Yale University, New Haven, CT 06510, USA.
  • Department of Physiology and Pharmacology, Karolinska Institutet (KI), SE-171 65 Solna, Sweden.
  • Department of Physiology, University of Kentucky, Lexington, KY 40506, USA.

ORCID-Profile: Shaojing Ye, Lin Leng, Kim Kultima

Förderung

  • NIAMS NIH HHS
  • NIDDK NIH HHS
  • NIH HHS
  • NIH
  • Knut and Alice Wallenberg Foundation
  • Magnus Bergvall Foundation

Zitieren

APA

Ye, S., Agalave, N. M., Ma, F., Mahmood, D. F. D., Al-Grety, A., Khoonsari, P. E., Leng, L., Svensson, C. I., Bucala, R., Kultima, K., & Vera, P. L. (2024). MIF-Modulated Spinal Proteins Associated with Persistent Bladder Pain: A Proteomics Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084484

Vancouver

Ye S, Agalave NM, Ma F, Mahmood DFD, Al-Grety A, Khoonsari PE, et al. MIF-Modulated Spinal Proteins Associated with Persistent Bladder Pain: A Proteomics Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084484

BibTeX
@article{Ye2024,
  author = {Ye, Shaojing and Agalave, Nilesh M and Ma, Fei and Mahmood, Dlovan F D and Al-Grety, Asma and Khoonsari, Payam E and Leng, Lin and Svensson, Camilla I and Bucala, Richard and Kultima, Kim and Vera, Pedro L},
  title = {MIF-Modulated Spinal Proteins Associated with Persistent Bladder Pain: A Proteomics Study},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25084484}
}
Kostenlos starten →